Skip to main content

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shah's full profile

Already have an account?

  • Office

    1653 W Congress Pkwy
    Fl 7
    Chicago, IL 60612
    Phone+1 312-942-3034

Summary

  • Dr. Ami Shah is a Pediatric Surgeon in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center, Captain James A. Lovell Federal Health Care Center, AMITA Health Hoffman Estates, AMITA Health Adventist Medical Center - Hinsdale, and Rush-Copley Medical Center. She received her medical degree from University of Illinois College of Medicine at Chicago and has been in practice 14 years. She is experienced in fetal surgery, pediatric general surgery, pediatric surgical oncology, pediatric colorectal surgery, and pediatric trauma and critical care.

Education & Training

  • University of Florida
    University of FloridaFellowship, Pediatric Surgery, 2010 - 2012
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Surgery, 2003 - 2010
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2003

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2007 - 2026
  • TX State Medical License
    TX State Medical License 2006 - 2010
  • American Board of Surgery Surgery
  • American Board of Surgery Pediatric Surgery

Awards, Honors, & Recognition

  • Member American Academy of Pediatrics
  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Lectures

  • A phase II study of pembrolizumab and capecitabine for triple-negative (TN) and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancer ... 
    2019 ASCO Annual Meeting - 6/1/2019

Professional Memberships